---
title: "What's Going On With P3 Health Partners Stock Monday?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286771327.md"
description: "P3 Health Partners ($PIII) shares fell 23.29% to $8.66 in premarket trading on Monday after a 180% surge on Friday. The decline is attributed to profit-taking by traders. Despite a quarterly loss of $1.72 per share, which beat estimates, sales missed expectations. Analyst Ben Haynor raised the price forecast from $4 to $14, maintaining a buy rating. The stock remains overbought, trading significantly above its moving averages."
datetime: "2026-05-18T12:09:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286771327.md)
  - [en](https://longbridge.com/en/news/286771327.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286771327.md)
---

# What's Going On With P3 Health Partners Stock Monday?

**P3 Health Partners Inc. ( PIII )** shares are trading lower on Monday. The drop follows a massive 180% surge during Friday’s session.

## Traders Lock In Profits

The Monday decline represents a natural correction. Retail traders are likely engaging in profit-taking after the historic rally. On Friday, intense buying pressure triggered an upside circuit breaker for the stock.

## Earnings Beat Wall Street Estimates

The Friday rally followed the company’s Thursday after-hours earnings report.

P3 Health Partners ( PIII ) reported a quarterly loss of $1.72 per share. This performance beat the analyst consensus estimate of a $3.28 loss per share. It also marks an improvement from the loss of $6.28 per share reported in the same period last year.

Quarterly sales reached $386.390 million, up from $373.225 million year-over-year. However, sales missed the analyst consensus estimate of $391.500 million, according to Benzinga Pro.

## Analyst Raises Price Forecast

Despite the mixed revenue, **Lake Street** analyst **Ben Haynor** expressed optimism on Friday. Haynor maintains a buy rating on P3 Health Partners ( PIII ). Notably, he raised the price forecast on the stock from $4 to $14.

The company adjusted its fiscal 2026 sales outlook. Management narrowed guidance from the previous $1.500 billion to $1.700 billion range down to $1.500 billion to $1.650 billion. Wall Street’s estimate sits at $1.539 billion.

## Short Interest Dynamics Shift

Recent data shows a slight decline in short interest. Short positions fell from 74,530 to 72,090 shares. This leaves 18.8% of the company’s public float sold short. Given the average daily volume of 9,500 shares, short sellers require 7.59 days to cover their positions.

## Critical Levels To Watch for PIII Stock

The bigger-picture trend is still pointed up, but the stock is extremely extended versus its moving averages—trading about 145.7% above the 20-day SMA ($3.50) and 65.7% above the 200-day SMA ($5.19).

RSI is the key momentum read here, and at 93.56 it’s deep in overbought territory.

The moving-average structure is mixed: the 20-day SMA is above the 50-day SMA (bullish near-term trend), but the 50-day SMA remains below the 200-day SMA.

-   **Key Resistance**: $9
-   **Key Support**: $8.50

**PIII Stock Price Activity:** P3 Health Partners ( PIII ) shares were down 23.29% at $8.66 during premarket trading on Monday, according to Benzinga Pro data.

_Image via Shutterstock_

### Related Stocks

- [PIII.US](https://longbridge.com/en/quote/PIII.US.md)
- [PIIIW.US](https://longbridge.com/en/quote/PIIIW.US.md)

## Related News & Research

- [P3 Health Partners Q1 revenue rises 4%, adjusted EBITDA turns positive](https://longbridge.com/en/news/286461585.md)
- [P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results | PIII Stock News](https://longbridge.com/en/news/280681546.md)
- [Oil edges lower as traders assess Middle East developments](https://longbridge.com/en/news/286980644.md)
- ['Fast Money' traders dissect the move in rates and how it impacted the equity market](https://longbridge.com/en/news/286970266.md)
- [Maintaining Hold Amid Weak Near-Term Results but Potential Profitability by 2027 for P3](https://longbridge.com/en/news/281430856.md)